IGM Biosciences Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
Hi, good afternoon, everyone. I am Brian Abrahams, Senior Biotech Analyst here at RBC Capital Markets. Our next presenting company is IGM Biosciences, represented by their CEO, Fred Schwarzer. Fred, thanks so much for joining us.
Thanks very much, Brian.
Questions & Answers
So, maybe, just to kick things off for those who are newer to the story, can you maybe start off by giving us an overview on your overall platform and why you guys have decided to use IgM antibodies rather than the more traditional IgGs? And we are also curious to learn how you have managed to overcome some of the challenges with IgM technology that have held the field back in the past?
Sure. Well we've decided to use IgMs (technical difficulty). Sorry for the technical difficulties. We managed to overcome a lot of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |